Infectious Diseases (except HIV/AIDS)

  1. Multiplex PCR Assays for Identifying all Major Severe Acute Respiratory Syndrome Coronavirus 2 Variants

    1. Ryan J. Dikdan
    2. Salvatore A.E. Marras
    3. Amanda P. Field
    4. Alicia Brownlee
    5. Alexander Cironi
    6. D. Ashley Hill
    7. Sanjay Tyagi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Designing an evidence-based Bayesian network for estimating the risk versus benefits of AstraZeneca COVID-19 vaccine

    1. Helen J. Mayfield
    2. Colleen L. Lau
    3. Jane E. Sinclair
    4. Samuel J. Brown
    5. Andrew Baird
    6. John Litt
    7. Aapeli Vuorinen
    8. Kirsty R. Short
    9. Michael Waller
    10. Kerrie Mengersen

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Implementation and Extended Evaluation of the Euroimmun Anti-SARS-CoV-2 IgG Assay and Its Contribution to the United Kingdom’s COVID-19 Public Health Response

    1. Ashley David Otter
    2. Abbie Bown
    3. Silvia D’Arcangelo
    4. Daniel Bailey
    5. Amanda Semper
    6. Jacqueline Hewson
    7. Matthew Catton
    8. Prem Perumal
    9. Angela Sweed
    10. Deborah Fox McKee
    11. Jessica Jones
    12. Heli Harvala
    13. Abigail Lamikanra
    14. Maria Zambon
    15. Nick Andrews
    16. Heather Whitaker
    17. Ezra Linley
    18. Alexander J. Mentzer
    19. Donal Skelly
    20. Julian C. Knight
    21. Paul Klenerman
    22. UKHSA Porton Euroimmun testing group
    23. Gayatri Amirthalingam
    24. Stephen Taylor
    25. Cathy Rowe
    26. Richard Vipond
    27. Tim Brooks

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike

    1. Andrew R Crowley
    2. Harini Natarajan
    3. Andrew P Hederman
    4. Carly A Bobak
    5. Joshua A Weiner
    6. Wendy Wieland-Alter
    7. Jiwon Lee
    8. Evan M Bloch
    9. Aaron AR Tobian
    10. Andrew D Redd
    11. Joel N Blankson
    12. Dana Wolf
    13. Tessa Goetghebuer
    14. Arnaud Marchant
    15. Ruth I Connor
    16. Peter F Wright
    17. Margaret E Ackerman

    • Curated by eLife

      Evaluation Summary:

      This study is aimed to determine whether infection or vaccination affects activation of pre-existing cross-reactive memory B cells. The data are clear and have implications for further development of new-generation of vaccines.

      (This preprint has been reviewed by eLife. We include the public reviews from the reviewers here; the authors also receive private feedback with suggested changes to the manuscript. The reviewers remained anonymous to the authors.)

    Reviewed by eLife, ScreenIT

    5 evaluationsAppears in 2 listsLatest version Latest activity

  5. How many lives do COVID vaccines save? Evidence from Israel

    1. Ronen Arbel
    2. Candace Makeda Moore
    3. Ruslan Sergienko
    4. Joseph Pliskin

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study

    1. Ruvim Izikson
    2. Daniel Brune
    3. Jean-Sébastien Bolduc
    4. Pierre Bourron
    5. Marion Fournier
    6. Tamala Mallett Moore
    7. Aseem Pandey
    8. Lucia Perez
    9. Nessryne Sater
    10. Anju Shrestha
    11. Sophie Wague
    12. Sandrine I Samson

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. The Persistence of Neutralising Antibodies up to 11 months after SARS-CoV-2 Infection in the Southern Region of New Zealand

    1. Reuben McGregor
    2. Alyson Craigie
    3. Susan Jack
    4. Arlo Upton
    5. Nicole J. Moreland
    6. James Ussher

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. In vitro characterisation and clinical evaluation of the diagnostic accuracy of a new antigen test for SARS-CoV-2 detection

    1. J.J. Montoya
    2. J.M. Rubio
    3. Y. Ouahid
    4. A. Lopez
    5. A. Madejon
    6. A.I. Gil-Garcia
    7. R.J. Hannam
    8. H.R.E. Butler
    9. P. Castan

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections

    1. Maxime Taquet
    2. Quentin Dercon
    3. Paul J. Harrison

    Reviewed by NCRC, ScreenIT

    2 evaluationsAppears in 2 listsLatest version Latest activity

  10. Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe

    1. Hannah G Rosenblum
    2. Julianne Gee
    3. Ruiling Liu
    4. Paige L Marquez
    5. Bicheng Zhang
    6. Penelope Strid
    7. Winston E Abara
    8. Michael M McNeil
    9. Tanya R Myers
    10. Anne M Hause
    11. John R Su
    12. Lauri E Markowitz
    13. Tom T Shimabukuro
    14. David K Shay

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 273 of 716 Next